ArticleCancers2024

Predictive Signatures for Responses to Checkpoint Blockade in Small-Cell Lung Cancer in Second-Line Therapy Do Not Predict Responses in First-Line Patients.

Jeffrey C Thompson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.